Search Results

AC220 50mg 50mg  | Purity Not Available

Adooq Bioscience

AC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.

More Information Supplier Page

AC220 5mg 5mg  | Purity Not Available

Adooq Bioscience

AC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.

More Information Supplier Page

AC220 200mg 200mg  | Purity Not Available

Adooq Bioscience

AC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.

More Information Supplier Page

AC220 10mg 10mg  | Purity Not Available

Adooq Bioscience

AC220 (Quizartinib) is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ?? 0.3 nM and >10 mM for MC4-11 and A375, respectively.

More Information Supplier Page

ABT-263 100mg 100mg  | Purity Not Available

Adooq Bioscience

ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 – Bcl-XL interactions with pro-apoptotic proteins .

More Information Supplier Page

ABT-263 10mg 10mg  | Purity Not Available

Adooq Bioscience

ABT-263 (Navitoclax) is a potent orally bioavailable SMI that is structurally related to ABT-737. ABT-263 disrupts Bcl-2 – Bcl-XL interactions with pro-apoptotic proteins .

More Information Supplier Page